Recall
FDAHealthJune 8, 2026

ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmace

⚠️ Subpotent Drug

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 8, 2026

US Nationwide.

What's affected?

Product
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
UPC
0316729447157
Lot code
D2401522

Additional details

Lot # D2401522, Exp Date: 06/2026.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 6432 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.